Erlotinib Recruiting Phase 3 Trials for EGFR NP_005219.2:p.L858R / Stage IIIA Non-Small Cell Lung Cancer AJCC v7 / Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 / Stage IB Non-Small Cell Lung Carcinoma AJCC v7 / Stage IIB Non-Small Cell Lung Carcinoma / ALK Gene Rearrangement / Stage II Non-Small Cell Lung Cancer AJCC v7 / Stage IIIA Non-Small Cell Lung Cancer / Stage IIA Non-Small Cell Lung Carcinoma / EGFR Exon 19 Deletion Mutation / Stage IB Non-Small Cell Lung Carcinoma / Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Treatment